New generation of poly(ortho esters): Synthesis, characterization, kinetics, sterilization and biocompatibility

Journal of Controlled Release

Volumn 48, Issue 2-3, 1997, Pages 115-129

  Zignani, M ^a   Merkli, A ^a   Sintzel, M B ^a   Bernatchez, S F ^a   Kloeti, W ^a   Heller, J ^b   Tabatabay, C ^a   Gurny, R ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Advanced Polymer Systems   (United States)

Author keywords

5 Fluorouracil; Biocompatibility; Mitomycin C; Ophthalmology; Poly(ortho esters); Release kinetics; Sterilization

Indexed keywords

EXCIPIENT; FLUOROURACIL; MITOMYCIN C; POLY(ORTHO ESTER); POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG RELEASE; DRUG STERILITY; DRUG SYNTHESIS; ESTERIFICATION; GLAUCOMA; KINETICS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RABBIT; RAT; SUBCONJUNCTIVAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030881084     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00050-3     Document Type: Article

References (76)

1. N.S. Choi and J. Heller, Drug delivery devices manufactured from poly(ortho esters) and poly(ortho carbonates), US Patent 4,093,709, June 6, 1978.
2. N.S. Choi and J. Heller, Structured orthoester and orthocarbonate drug delivery devices, US Patent 4,131,648, December 26, 1978.
3. N.S. Choi and J. Heller, Erodible agent releasing device comprising poly(ortho esters) and poly(ortho carbonates), US Patent 4,138,344, February 6, 1979.
4. N.S. Choi and J. Heller, Novel orthoester polymers and orthocarbonate polymers, US Patent 4,180,646, December 25, 1979.
5. J. Heller, D.W.H. Penhale and R.F. Helwing, Preparation of poly(ortho esters) by the reaction of diketene acetals and polyols, J. Polymer Sci. 18 (1980) 619-624.
6. N.S. Choi and J. Heller, Polymers of di (and higher functionality) ketene acetals and polyols, US Patent 4,304,767, December 8, 1981.
7. J. Heller, S.Y. Ng, D.W.H. Penhale, B.K. Fritzinger, L.M. Sanders, R.A. Burns, M.G. Gaynon and S.S. Bhosale, Use of poly(ortho esters) for the controlled release of 5-fluorouracil and LHRH analogue, J. Control. Release 6 (1987) 217-224.
8. A. Merkli, J. Heller, C. Tabatabay and R. Gurny, Semi-solid hydrophobic bioerodible poly(ortho ester) for potential application in glaucoma filtering surgery. J. Control. Release 29 (1994) 105-112.
9. A. Merkli, J. Heller, C. Tabatabay and R. Gurny, Synthesis and characterization of a new biodegradable semi-solid poly (ortho ester) for drug delivery systems, J. Biomater. Sci. Polymer (Edn). 4 (1993) 505-516.
10. The Fluorouracil Filtering Surgery Study Group, Fluoro-uracil filtering surgery study one-year follow-up, Am. J. Ophthalmol. 108 (1989) 625-635.
11. The Fluorouracil Filtering Surgery Study Group, Three-year follow-up of the fluorouracil filtering surgery study, Am. J. Ophthalmol. 115 (1993) 82-92.
12. The Fluorouracil Filtering Surgery Study Group, Five-year follow-up of the fluorouracil filtering surgery study, Am. J. Ophthalmol. 121 (1996) 349-366.
13. L.M. Vistnes, E.E. Schmitt, G.A. Ksander, E.H. Rose, W.J. Balkenhol and C.L. Coleman, Evaluation of a prototype therapeutic system for prolonged, continuous topical delivery of homosulfanilamide in the management of Pseudomonas burn wound sepsis, Surgery 79 (1976) 690-696.
14. R.C. Capozza, E.E. Schmitt and L.R. Sendelbeck, Development of chronomers for narcotic antagonists, Nat. Inst. Drug Res. Monogr. Ser. 4 (1976) 39-42.
15. R.C. Capozza, L.R. Sendelbeck and W.J. Balkenhol, Preparation and evaluation of a bioerodible naltrexone delivery system, In: R.G. Kostelnik. (Ed.), Polymeric Delivery Systems, Gordon and Breach, New York, 1978, pp. 59-73.
16. B.B. Pharriss,V.A. Place, L.R. Sendelbeck and E.E. Schmitt, Steroid delivery systems for contraception, J. Reprod. Med. 17 (1976) 91-97.
17. E.M. Pinholt, E. Solheim and E. Sudmann, Bone induction by composite of bioerodible polyorthoester and demineralized bone matrix in rats, Acta Orthop. Scand. 62 (1991) 466-480.
18. E. Solheim, E.M. Pinholt, G. Bang and E. Sudmann, Regeneration of calvaria defects by a composite of bioerodible polyorthoester and demineralized bone in rats, J. Neurosurg. 76 (1992) 275-279.
19. E. Solheim, E.M. Pinholt, R. Andersen, G. Bang, B. Sudmann and E. Sudmann, The effect of a composite of polyorthoester and demineralized bone on the healing of large segmental defects of the radius in rats, J. Bone Joint Surg. 74-A (1992) 1456-1463.
20. B. Sudmann, O.G. Anfinsen, G. Bang, R. Koppang, S.O. Stolen, H.S. Koppang and E. Sudmann, Assessment in rats of a new bioerodible bone-wax-like polymer, Acta Orthop. Scand. 64 (1993) 336-339.
21. E. Solheim, E.M. Pinholt, G. Bang and E. Sudmann, Effect of local hemostatics on bone induction in rats: a comparative study of bone wax, fibrin-collagen paste, and bioerodible polyorthoester with and without gentamicin, J. Biomed. Mater. Res. 26 (1992) 791-800.
22. L.B. Engesaeter, B. Sudmann and E. Sudmann, Fracture healing in rats inhibited by locally administered indomethacin, Acta Orthop. Scand. 63 (1992) 330-333.
23. E. Solheim, E.M. Pinholt, G. Bang and E. Sudmann, Inhibition of heterotopic osteogenesis in rats by a new bioerodible system for local delivery of indomethacin, J. Bone Joint Surg. 74-A (1992) 705-712.
24. E. Solheim, E.M. Pinholt, R. Andersen, G. Bang and E. Sudmann, Local delivery of indomethacin by a polyorthoester inhibits reossification of experimental bone deffects, J. Biomed. Mater. Res. 29 (1995) 1141-1146.
25. J. Heller, D.W.H. Penhale, R.F. Helwing and B.K. Fritzinger, Release of norethindrone from poly(ortho esters), Polymer Eng. Sci. 21 (1981) 727-731.
26. J. Heller, D.W.H. Penhale, R.F. Helwing and B.K. Fritzinger, Release of norethindrone from polyacetals and poly(ortho esters), Am. Inst. Chem. Eng. 77 (1981) 28-36.
27. R.V. Sparer, C. Shih, C.D. Ringeisen and K.J. Himmelstein, Controlled release from erodible poly(ortho ester) drug delivery systems, J. Control. Release 1 (1984) 28-32.
28. C. Shih, T. Higuchi and K.J. Himmelstein, Drug delivery from catalysed erodible polymeric matrices of poly(ortho ester)s, Biomaterials 5 (1984) 237-240.
29. C. Shih, S. Lucas and G.M. Zentner, Acid catalyzed poly-(ortho ester) matrices for intermediate term drug delivery, J. Control. Release 15 (1991) 55-63.
30. J. Heller, Controlled drug release from poly(ortho esters)-a surface eroding polymer, J. Control. Release 2 (1985) 167-177.
31. J. Heller, B.K. Fritzinger, S.Y. Ng and D.W.H. Penhale, In vitro and in vivo release of levonorgestrel from poly(ortho esters). II. Crosslinked polymers, J. Control. Release 1 (1985) 233-238.
32. J. Heller, B.K. Fritzinger, S.Y. Ng and D.W.H. Penhale, In vitro and in vivo release of levonorgestrel from poly(ortho esters). I. Linear polymers, J. Control. Release 1 (1985) 225-232.
33. J.A. Fix and P.S. Leppert, Erodible poly(ortho ester) drug delivery systems: in vitro erosion in canine and USP-simulated gastric juice, J. Control. Release 4 (1986) 87-95.
34. J. Heller, D.W.H. Penhale, B.K. Fritzinger and S.Y. Ng, The effect of copolymerized 9,10-dihydroxystearic acid on erosion rates of poly(ortho esters) and its use in the delivery of levonorgestrel, J. Control. Release 5 (1987) 173-177.
35. A.W. Chow, R.D. Hamlin and J. Heller, Cure behavior of neat and drug-loaded poly(ortho ester) bioerodible implants, J. Control. Release 9 (1989) 123-131.
36. J. Heller, D.W.H. Penhale and S.H. Pangburn, Chemically self-regulated drug delivery systems, In: C. Migliaresi. (Ed.), Progress in Biomedical Engineering 5, Elsevier Science Publisher, Amsterdam, 1988, pp. 175-188.
37. Y.F. Maa and J. Heller, Controlled release of 5-fluorouracil, J. Control. Release 13 (1989) 11-19.
38. J. Heller, A.C. Chang, G. Rodd and G.M. Grodsky, Release of insulin from pH-sensitive poly(ortho esters), J. Control. Release 13 (1990) 295-302.
39. Y.F. Maa and J. Heller, Controlled release of naltrexone pamoate from linear poly(ortho esters), J. Control. Release 14 (1990) 21-28.
40. K.V. Roskos, J.A. Teft, B.K. Fritzinger and J. Heller, Development of a morphine-triggered naltrexone delivery system, J. Control. Release 19 (1992) 145-160.
41. L.E. Appel, R. Balena, M. Cortese, E. Opas, G. Rodan, G. Seedor and G.M. Zentner, In vitro characterization and in vivo efficacy of a prostaglandin E2/poly(ortho ester) implant for bone growth promotion, J. Control. Release 26 (1993) 77-85.
42. C. Shih, J.A. Fix and R.L. Seward, In vivo and in vitro release of ivermectin from poly(ortho ester) matrices. I. Crosslinked prepared form ketene acetal end capped-prepolymer, J. Control. Release 25 (1993) 155-162.
43. L.W. Seymour, R. Duncan, J. Duffy, S.Y. Ng and J. Heller, Poly(ortho ester) matrices for controlled release of the antitumour agent 5-fluorouracil, J. Control. Release 31 (1994) 201-206.
44. A.U. Daniels, K.P. Andriano, W.P. Smutz, M.K.O. Chang and J. Heller, Evaluation of absorbable poly(ortho esters) for use in surgical implants, J. Appl. Biomater. 5 (1994) 51-64.
45. M.S. Taylor, A.U. Daniels, K.P. Andriano and J. Heller, Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products, J. Appl. Biomater. 5 (1994) 151-157.
46. T.F. Vandamme and J. Heller, Poly(ortho esters) as bioerodible matrices for the controlled delivery of pyrimethamine in chemoprophylaxis of malaria, J. Control. Release 36 (1995) 209-213.
47. J. Heller, S.Y. Ng, B.K. Fritzinger and K.V. Roskos, Controlled drug release from bioerodible hydrophobic ointments, Biomaterials 11 (1990) 235-237.
48. P. Wuthrich, S.Y. Ng, B.K. Fritzinger, K.V. Roskos and J. Heller, Pulsatile and delayed release of lysozyme from ointment like poly(ortho ester), J. Control. Release 21 (1992) 191-200.
49. K.V. Roskos, B.K. Fritzinger, S.S. Rao, G.C. Armitage and J. Heller, Development of drug delivery system for the treatment of periodontal disease based on bioerodable poly(ortho ester), Biomaterials 16 (1995) 313-317.
50. A. Merkli, J. Heller, C. Tabatabay and R. Gurny, The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester), J. Control. Release. 33 (1995) 415-421.
51. S.F. Bernatchez, Q.H. Zhao, A. Merkli, C. Tabatabay, J. Heller, J.M. Anderson and R. Gurny, Biotolerance of a semi-solid hydrophobic biodegradable poly(ortho ester) for controlled drug delivery, J. Biomed. Mater. Res. 27 (1993) 677-681.
52. S.F. Bernatchez, A. Merkli, T. Le Minh, C. Tabatabay, J.M. Anderson and R. Gurny, Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil, J. Biomed. Mater. Res. 28 (1994) 1037-1046.
53. A. Merkli, J. Heller, C. Tabatabay and R. Gurny, Purity and stability assesment of a semi-solid poly(ortho ester) used in drug delivery system, Biomaterials 17 (1996) 897-902.
54. M. Zignani, S.F. Bernatchez, T. Le Minh, C. Tabatabay, J.M. Anderson and R. Gurny, Subconjunctival biocompatibility of a viscous bioerodible poly(ortho ester). J. Biomed. Mater. Res. (1997) in press.
55. A. Merkli, J. Heller, C. Tabatabay and R. Gurny, Gamma sterilization of a semi-solid poly(ortho ester) designed for drug delivery -Validation and radiation effects, Pharm. Res. 11 (1994) 1485-1491.
56. R. Marchant, A. Hiltner, C. Hamlin, A. Rabinovitch, R. Slobodkin and J.M. Anderson, In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel, J. Biomed. Mater. Res. 17 (1983) 301-325.
57. K. Yamaguchi and J.M. Anderson, Biocompatibility studies of naltrexone sustained release formulations, J. Control. Release 19 (1992) 299-314.
58. Enquête: solvants résiduels, Pharmeuropa 2 (1990) 142-146.
59. J. Rabiant, La limitation des solvants résiduels: aspect réglementaire, S.T.P. Pharma Sci. 1 (1991) 278-283.
60. J. Heller, Y.F. Maa, S.Y. Ng and R. Duncan, Recent developments in the synthesis and utilization of poly(ortho esters), J. Control. Release 16 (1991) 3-14.
61. S.M. Li, H. Garreau and M. Vert, Structure-property relationships in the case of the degradation of massive poly(a-hydroxy acids) in aqueous media, Part 2, Degradation of lactide-glycolide copolymers: PLA37.5GA and PLA75GA25, J. Mater. Sci. 1 (1990) 131-139.
62. M. Vert, S.M. Li, G. Spenlehauer and P. Guerin, Bioresorbability and biocompatibility of aliphatic polyesters, J. Mater. Sci. 3 (1992) 432-446.
63. K.A. Athanasiou, G.G. Niedrauer and C.M. Agrawal, Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers, Biomaterials 17 (1996) 93-102.
64. V.H.L. Lee, Esterases activities in adult rabbit eyes, J. Pharm. Sci., 72 (1982) 239-244.
65. The Sigma-Aldrich Library of Chemical Safety Data, Milwaukee, Sigma-Aldrich, 1988.
66. J. Sekizawa, K. Yasuhara, Y. Suyama, S. Yamanaka, M. Tobe and M. Nishimura, A simple method for screening assesment of skin and eye irritation, J. Toxicol. Sci. 19 (1994) 25-35.
67. H. Wheeler-Aceto, F. Porreca and A. Cowan, The rat formalin test: comparison of noxious agents, Pain 40 (1990) 229-238.
68. J. Heller, D.W.H. Penhale, B.K. Fritzinger and S.Y. Ng, Controlled release of contraceptive agents from poly(ortho esters), in: G.I. Zatuchni and A. Goldsmith. (Eds.), PARFR Series on Fertility Regulatory, Harper and Row, Philadelphia, PA, 1984, pp. 113-128.
69. C.A. Bunton and R.H. de Wolfe, The hydrolysis of carboxilic ortho ester, J. Org. Chem. 30 (1965) 1371.
70. T.H. Nguyen, K.J. Himmelstein and T. Higuchi, Some equilibrium and kinetic aspects of water sorption in poly-(ortho ester)s, Int. J. Pharm. 25 (1985) 1-12.
71. T.H. Nguyen, C. Shih, K.J. Himmelstein and T. Higuchi, Hydrolysis of some poly(ortho ester)s in homogeneous solutions, J. Pharm. Sci. 73 (1984) 1563-1568.
72. J. Hoborn, Die Entwicklung der Ethylenoxidsterilisation: technologische Aspekte und toxickologische Sicherheit, J. Pharm. Technol. 6 (1985) 34-35.
73. M.B. Sintzel, M. Zignani, C. Tabatabay and R. Gurny, Influence of irradiation sterilization on semi-solid poly(ortho ester), Proc. Eur. J. Pharm. Biopharm. 42 (1996).
74. J. Heller, S.S. Rao, B.K. Fritzinger, G.C. Armitage and K.V. Roskos, Development of a tetracycline delivery system for the periodontal disease, In: T. Okano, N. Ogata, J. Feijen and S.W. Kim. (Eds.), Advances in Biomedical Polymers in Biomedical Engineering and Drug Delivery Systems, Spring Verlag, 1996, pp. 106-110.
75. H.F. Smyth, U.C. Pozzani, C.S. Weil, M.J. Tallant and C.P. Carpentier, Experimental toxicity and metabolism of 1,2,6-hexanetriol, Toxicol. Appl. Pharmacol. 15 (1969) 282-286.
76. B.M. Mitruka and H.M. Rawnsley, Reference Values in Experimental Animals, Masson, New York, 1977, pp. 82-84.